EMD Millipore opens Shanghai facility
EMD Millipore, the life science division of Merck KGaA of Germany, has opened a biopharmaceutical technical and training centre in Shanghai, China.
EMD Millipore, the life science division of Merck KGaA of Germany, has opened a biopharmaceutical technical and training centre in Shanghai, China. The facility will provide support, training and validation services to the company’s biopharmaceutical customers with operations in China.
“We are responding to China’s commitment to strengthen regulatory requirements designed to ensure drug safety,” said Jean-Paul Mangeolle, head of process solutions. “Our new biopharmaceutical technical centre is unique in that we can support and even train our pharmaceutical customers to meet the new Chinese and global regulations. Today we have taken a significant step not only expanding our 30 years of local offerings in China, but also to support the effort to produce safe, quality drugs in this important and fast growing region.”
The centre is located in Zhangjiang Hi-Tech Park and will support biopharmaceutical manufacturers, allowing local and regional customers to investigate, explore and optimize their upstream and downstream processes as well as environmental monitoring processes with the support of the company’s local, regional and international experts. Similar facilities are run by the company in Singapore, Japan, India, France, North America and Brazil.
For more information visit www.millipore.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
